"The purpose of pursuing this listing has been predicated on the last three months of advanced discussions with two Fortune 500 Companies, as well as, North American, European and Australian-based investors, and a global medical devices distribution company;"
"whose sentiments collectively feel that a secondary listing, with a preference for a North American Exchange (such as the NASDAQ-OTC Stock Exchange) would afford greater profile and liquidity as well as ease of transaction facilitation and financial confidence given the significant growth program the business is executing across America."
we already know " a global medical devices distribution company" is Omron Healthcare.
KSX will announe who are the "two Fortune 500 Companies" for us soon!
KSX Price at posting:
1.2¢ Sentiment: Buy Disclosure: Held